Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Xanthoulea, Sofia ^a   Thelen, Melanie ^a   Pöttgens, Chantal ^a   Gijbels, Marion J J ^a   Lutgens, Esther ^a   de Winther, Menno P J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CD68 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; P55 TUMOR NECROSIS FACTOR RECEPTOR; RANTES; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CHEMOKINE; CYTOKINE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; AORTA ATHEROSCLEROSIS; AORTA DISSECTING ANEURYSM; AORTA RUPTURE; AORTA SINUS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; GENE EXPRESSION REGULATION; LETHALITY; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WILD TYPE; ANIMAL; ATHEROSCLEROSIS; GENETICS; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; CHEMOKINES; CYTOKINES; MICE; MICE, KNOCKOUT; RECEPTORS, LDL; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION;

EID: 67650234477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006113     Document Type: Article

References (37)

1. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874.
2. Shimizu K, Mitchell RN, Libby P (2006) Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26: 987-994.
3. Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10: 45-65.
4. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, et al. (2004) Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 24: 2137-2142.
5. Canault M, Peiretti F, Mueller C, Kopp F, Morange P, et al. (2004) Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus. Atherosclerosis 172: 211-218.
6. Boesten LS, Zadelaar AS, van Nieuwkoop A, Gijbels MJ, de Winther MP, et al. (2005) Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice. Cardiovasc Res 66: 179-185.
7. Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, et al. (2005) Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 180: 11-17.
8. Blessing E, Bea F, Kuo CC, Campbell LA, Chesebro B, et al. (2004) Lesion progression and plaque composition are not altered in older apoE-/- mice lacking tumor necrosis factor-alpha receptor p55. Atherosclerosis 176: 227-232.
9. Schreyer SA, Peschon JJ, LeBoeuf RC (1996) Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 271: 26174-26178.
10. Xanthoulea S, Gijbels MJ, van der Made I, Mujcic H, Thelen M, et al. (2008) p55 Tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice. Cardiovasc Res.
11. Zhang L, Peppel K, Sivashanmugam P, Orman ES, Brian L, et al. (2007) Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol 27: 1087-1094.
12. Fiane AE, Videm V, Lingaas PS, Heggelund L, Nielsen EW, et al. (2003) Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 108: 849-856.
13. Hamano K, Li TS, Takahashi M, Kobayashi T, Shirasawa B, et al. (2003) Enhanced tumor necrosis factor- alpha expression in small sized abdominal aortic aneurysms. World J Surg 27: 476-480.
14. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJJ, et al. (2008) Endothelial Cell-Specific NF-[kappa]B Inhibition Protects Mice from Atherosclerosis. Cell Metabolism 8: 372-383.
15. Daugherty A, Manning MW, Cassis LA (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105: 1605-1612.
16. Deng GG, Martin-McNulty B, Sukovich DA, Freay A, Halks-Miller M, et al. (2003) Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 92: 510-517.
17. Manning MW, Cassi LA, Huang J, Szilvassy SJ, Daugherty A (2002) Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med 7: 45-54.
18. Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W (1993) Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 177: 1277-1286.
19. Neumann B, Machleidt T, Lifka A, Pfeffer K, Vestweber D, et al. (1996) Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol 156: 1587-1593.
20. Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27: 2292-2301.
21. Xanthoulea S, Curfs DM, Hofker MH, de Winther MP (2005) Nuclear factor kappaB signaling in macrophage function and atherogenesis. Curr Opin Lipidol 16: 536-542.
22. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, et al. (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10: 416-421.
23. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, et al. (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 101: 10679-10684.
24. Mullick AE, Soldau K, Kiosses WB, Bell TA 3rd, Tobias PS, et al. (2008) Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 205: 373-383.
25. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581.
26. Zernecke A, Shagdarsuren E, Weber C (2008) Chemokines in Atherosclerosis. An Update. Arterioscler Thromb Vasc Biol.
27. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, et al. (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45: 1169-1196.
28. Feingold KR, Serio MK, Adi S, Moser AH, Grunfeld C (1989) Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 124: 2336-2342.
29. Memon RA, Grunfeld C, Moser AH, Feingold KR (1993) Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 132: 2246-2253.
30. Kleemann R, Zadelaar S, Kooistra T (2008) Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79: 360-376.
31. Schonbeck U, Sukhova GK, Gerdes N, Libby P (2002) T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol 161: 499-506.
32. Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN (2004) Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest 114: 300-308.
33. King VL, Lin AY, Kristo F, Anderson TJ, Ahluwalia N, et al. (2009) Interferongamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation 119: 426-435.
34. Hui-Yuen JS, Duong TT, Yeung RS (2006) TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 176: 6294-6301.
35. Newburger JW, Fulton DR (2007) Kawasaki Disease. Curr Treat Options Cardiovasc Med 9: 148-158.
36. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, et al. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
37. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, et al. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92: 883-893.